Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

v3.20.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash flows from operating activities:    
Net loss $ (3,353) $ (1,689)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 5,868 6,263
Amortization of debt issuance and warrant costs 827 845
Stock-based compensation 307 263
Change in fair value of stock warrants (1,159) 161
Change in fair value of interest rate cap 0 90
Loss on disposal of assets 439 5
Increases and decreases in operating assets and liabilities:    
Accounts receivable 306 249
Prepaid expenses, inventories and other 1,533 (1,477)
Deferred taxes (2) 51
Deferred revenue (109) 2,000
Accounts payable and accrued expenses (1,732) (1,048)
Net cash provided by operating activities 2,925 5,713
Cash flows from investing activities:    
Purchase of property and equipment (1,883) (5,662)
Other 11 (563)
Net cash used in investing activities (1,872) (6,225)
Cash flows from financing activities:    
Proceeds from Senior Secured Notes borrowings 0 10,000
Proceeds from CARES Act unsecured loans 5,606 0
Payment of debt discount and issuance costs (1,284) (1,182)
Repayment of Senior Secured Notes (825) (800)
Repayment of finance lease obligation (369) (403)
Proceeds from exercise of stock options 0 45
Net cash provided by financing activities 3,128 7,660
Net increase in cash, cash equivalents and restricted cash 4,181 7,148
Cash, cash equivalents and restricted cash, beginning of period 29,851 20,634
Cash, cash equivalents and restricted cash, end of period 34,032 27,782
Supplemental Cash Flow Information:    
Cash paid for interest, net of amounts capitalized 6,324 6,962
Non-Cash Investing Activities:    
Accounts payable related capital expenditures $ 265 $ 651